THTX vs. NRXP, ENLV, ACXP, DARE, APRE, VIRX, ACST, UBX, SPRB, and LPCN
Should you be buying Theratechnologies stock or one of its competitors? The main competitors of Theratechnologies include NRx Pharmaceuticals (NRXP), Enlivex Therapeutics (ENLV), Acurx Pharmaceuticals (ACXP), Daré Bioscience (DARE), Aprea Therapeutics (APRE), Viracta Therapeutics (VIRX), Acasti Pharma (ACST), Unity Biotechnology (UBX), Spruce Biosciences (SPRB), and Lipocine (LPCN). These companies are all part of the "pharmaceutical preparations" industry.
NRx Pharmaceuticals (NASDAQ:NRXP) and Theratechnologies (NASDAQ:THTX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, community ranking, institutional ownership, analyst recommendations and media sentiment.
Theratechnologies received 22 more outperform votes than NRx Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave NRx Pharmaceuticals an outperform vote while only 52.73% of users gave Theratechnologies an outperform vote.
In the previous week, NRx Pharmaceuticals had 6 more articles in the media than Theratechnologies. MarketBeat recorded 9 mentions for NRx Pharmaceuticals and 3 mentions for Theratechnologies. NRx Pharmaceuticals' average media sentiment score of 0.96 beat Theratechnologies' score of 0.53 indicating that Theratechnologies is being referred to more favorably in the news media.
4.3% of NRx Pharmaceuticals shares are owned by institutional investors. 21.1% of NRx Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
NRx Pharmaceuticals has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500. Comparatively, Theratechnologies has a beta of 1.41, indicating that its share price is 41% more volatile than the S&P 500.
NRx Pharmaceuticals has a net margin of 0.00% compared to NRx Pharmaceuticals' net margin of -23.04%.
Theratechnologies has higher revenue and earnings than NRx Pharmaceuticals. Theratechnologies is trading at a lower price-to-earnings ratio than NRx Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Summary
Theratechnologies beats NRx Pharmaceuticals on 8 of the 14 factors compared between the two stocks.
Get Theratechnologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for THTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding THTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Theratechnologies Competitors List
Related Companies and Tools
